Sequence capture and next generation resequencing of the MHC region highlights potential transplantation determinants in HLA identical Haematopoietic stem cell transplantation

DNA Research

Volumn 18, Issue 4, 2011, Pages 201-210

  Pröll, Johannes ^a   Danzer, Martin ^a   Stabentheiner, Stephanie ^a   Niklas, Norbert ^a   Hackl, Christa ^a   Hofer, Katja ^a   Atzmüller, Sabine ^a   Hufnagl, Peter ^b   Glly, Christian ^c   Hauser, Hanns ^d   Krieger, Otto ^d   Gabriel, Christian ^a  

^a Red Cross Transfusion Service for Upper Austria   (Austria)

^b Roche Diagnostics GmbH   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d ELISABETHINEN HOSPITAL   (Austria)

Author keywords

human resequencing; MHC; transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; HLA ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; DISEASE COURSE; DNA MICROARRAY; GENE LOCUS; GENE SEQUENCE; GENOME ANALYSIS; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; IMMUNE RESPONSE GENE; IMMUNOCOMPETENCE; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROARRAY ANALYSIS; PYROSEQUENCING; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TOLERANCE VERSUS ACTIVITY MECHANISM; TREATMENT OUTCOME;

EPITOPES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 80052015071     PISSN: 13402838     EISSN: 17561663     Source Type: Journal    
DOI: 10.1093/dnares/dsr008     Document Type: Article

References (26)

1. Spellman, S., Setterholm, M., Maiers, M., et al. 2008, Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry, Biol. Blood Marrow Transplant., 14, 37-44.
2. 1999, Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium, Nature, 401, 921-3.
3. Stewart, C. A., Horton, R., Allcock, R. J., et al. 2004, Complete MHC haplotype sequencing for common disease gene mapping, Genome Res., 14, 1176-87. (Pubitemid 38811554)
4. Horton, R., Gibson, R., Coggill, P., et al. 2008, Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project, Immunogenetics, 60, 1-18.
5. Davies, J. L., Kawaguchi, Y., Bennett, S. T., et al. 1994, A genome-wide search for human type 1 diabetes susceptibility genes, Nature, 371, 130-6. (Pubitemid 24284009)
6. Goulder, P. J. and Watkins, D. I. 2008, Impact of MHC class I diversity on immune control of immunodeficiency virus replication, Nat. Rev. Immunol., 8, 619-30.
7. Lee, S. J., Klein, J., Haagenson, M., et al. 2007, High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation, Blood, 110, 4576-83. (Pubitemid 351377826)
8. Petersdorf, E. W. 2004, HLA matching in allogeneic stem cell transplantation, Curr. Opin. Hematol., 11, 386-91. (Pubitemid 39491431)
9. Petersdorf, E. W., Malkki, M., Gooley, T. A., Martin, P. J. and Guo, Z. 2007, MHC haplotype matching for unrelated hematopoietic cell transplantation, PLoS Med., 4, e8.
10. Gabriel, S. B., Schaffner, S. F., Nguyen, H., et al. 2002, The structure of haplotype blocks in the human genome, Science, 296, 2225-9. (Pubitemid 34680308)
11. Guo, Z., Hood, L., Malkki, M. and Petersdorf, E. W. 2006, Long-range multilocus haplotype phasing of the MHC, Proc. Natl. Acad. Sci. USA, 103, 6964-9.
12. Bentley, G., Higuchi, R., Hoglund, B., et al. 2009, Highresolution, high-throughput HLA genotyping by nextgeneration sequencing, Tissue Antigens, 74, 393-403.
13. Gabriel, C., Danzer, M., Hackl, C., et al. 2009, Rapid high-throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification, Hum. Immunol., 70, 960-4.
14. Lind, C., Ferriola, D., Mackiewicz, K., et al. 2010, Nextgeneration sequencing: the solution for high-resolution, Unambiguous HLA Typing, Hum. Immunol., 71, 1033-42.
15. Fojo, T. and Menefee, M. 2007, Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents, Ann. Oncol., 18(Suppl. 5), v3-v8.
16. Zughaier, S., Karna, P., Stephens, D. and Aneja, R. 2010, Potent anti-inflammatory activity of novel microtubulemodulating brominated noscapine analogs, PLoS One, 5, e9165.
17. Penack, O., Holler, E. and van den Brink, M. R. 2010, Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors, Blood, 115, 1865-72.
18. Shaw, R. K., Smollett, K., Cleary, J., et al. 2005, Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells, Infect. Immun., 73, 4385-90. (Pubitemid 40923185)
19. van Oosterhout, C. 2009, Transposons in the MHC: the Yin and Yang of the vertebrate immune system, Heredity, 103, 190-1.
20. Wee, Y. M., Choi, M. Y., Kang, C. H., et al. 2010, The synergistic effect of tautomycetin on cyclosporine a-mediated immunosuppression in a rodent islet allograft model, Mol. Med., 16, 298-306.
21. Zhu, Q., Meng, L., Hsu, J. K., Lin, T., Teishima, J. and Tsai, R. Y. 2009, GNL3L stabilizes the TRF1 complex and promotes mitotic transition, J. Cell Biol., 185, 827-39.
22. Wolfel, C., Lennerz, V., Lindemann, E., et al. 2008, Dissection and molecular analysis of alloreactive CD8\+ T cell responses in allogeneic haematopoietic stem cell transplantation, Cancer Immunol. Immunother., 57, 849-57.
23. Gonzalez, S., Groh, V. and Spies, T. 2006, Immunobiology of human NKG2D and its ligands, Curr. Top. Microbiol. Immunol., 298, 121-38.
24. Suarez-Alvarez, B., Lopez-Vazquez, A., Baltar, J. M., Ortega, F. and Lopez-Larrea, C. 2009, Potential role of NKG2D and its ligands in organ transplantation: new target for immunointervention, Am. J. Transplant., 9, 251-7.
25. Winget, J. M. and Mayor, T. 2010, The diversity of ubiquitin recognition: hot spots and varied specificity, Mol. Cell, 38, 627-35.
26. Ashton-Chess, J., Mai, H. L., Jovanovic, V., et al. 2010, Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection, Kidney Int., 77, 880-90.